AlphaCentric Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-523
Closed -$104K 298
2025
Q4
$104K Buy
+523
New +$106K 0.1% 218
2024
Q4
$153K Sell
1,213
-213
-15% -$31.7K 0.15% 141
2024
Q3
$237K Sell
1,426
-40
-3% -$6.05K 0.18% 123
2024
Q2
$195K Buy
1,466
+584
+66% +$70.3K 0.14% 121
2024
Q1
$92.7K Sell
882
-119
-12% -$10.7K 0.06% 199
2023
Q4
$75.6K Buy
+1,001
New +$63.5K 0.05% 182

Other funds holding THC

AlphaCentric Advisors's THC Position: Q1 2026 in Review

AlphaCentric Advisors sold out of Tenet Healthcare (THC) in Q1 2026, closing a stake of 523 shares — an estimated $104K sold.

AlphaCentric Advisors first reported a position in THC in Q4 2023 and held it in 6 quarters. The position peaked at $237K in Q3 2024. 693 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • AlphaCentric Advisors reported no remaining Tenet Healthcare position as of Q1 2026 after selling out during the quarter.
  • AlphaCentric Advisors sold 523 Tenet Healthcare shares in Q1 2026, an estimated $104K.
  • AlphaCentric Advisors first reported a position in Tenet Healthcare in Q4 2023 and held it in 6 quarters.
  • AlphaCentric Advisors's Tenet Healthcare position peaked at $237K in Q3 2024.
  • 693 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.